Ultralife Corporation
ULBI
$6.86
$0.060.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.29M | 5.38M | 6.41M | 8.96M | 10.03M |
| Total Depreciation and Amortization | 4.95M | 4.54M | 4.16M | 3.94M | 3.94M |
| Total Amortization of Deferred Charges | 192.00K | 140.00K | 91.00K | 60.00K | 64.00K |
| Total Other Non-Cash Items | 1.42M | 1.85M | 2.09M | 2.01M | 2.38M |
| Change in Net Operating Assets | 7.25M | 8.17M | 3.89M | 1.05M | -6.03M |
| Cash from Operations | 17.10M | 20.09M | 16.64M | 16.02M | 10.39M |
| Capital Expenditure | -3.20M | -2.46M | -1.93M | -2.33M | -2.27M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -48.02M | -48.02M | -48.02M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -51.22M | -50.48M | -49.95M | -2.33M | -2.27M |
| Total Debt Issued | 55.00M | 55.00M | 55.00M | 1.00M | 2.95M |
| Total Debt Repaid | -15.44M | -25.93M | -25.75M | -19.21M | -15.68M |
| Issuance of Common Stock | 124.00K | 1.31M | 2.00M | 2.17M | 3.12M |
| Repurchase of Common Stock | -- | -- | -- | -8.00K | -8.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.42M | -1.39M | -1.39M | -68.00K | -- |
| Cash from Financing | 38.27M | 28.99M | 29.86M | -16.12M | -9.62M |
| Foreign Exchange rate Adjustments | 108.00K | 24.00K | 34.00K | -97.00K | -94.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.25M | -1.38M | -3.42M | -2.53M | -1.59M |